Original language | English (US) |
---|---|
Article number | 104557 |
Journal | Neurobiology of Disease |
Volume | 133 |
DOIs | |
State | Published - Jan 2020 |
ASJC Scopus subject areas
- Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neurobiology of Disease, Vol. 133, 104557, 01.2020.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Preface
T2 - Discovery and development of better medical countermeasures for chemical threats targeting the nervous system
AU - Jett, David A.
AU - Galanopoulou, Aristea S.
AU - Moshé, Solomon L.
N1 - Funding Information: ASG acknowledges grant support by NINDS RO1 NS091170, U54 NS100064, the US Department of Defense (W81XWH-13-1-0180), and research funding from the Heffer Family and the Segal Family Foundations and the Abbe Goldstein / Joshua Lurie and Laurie Marsh/ Dan Levitz families. SLM is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIH U54 NS100064 (EpiBioS4Rx), and NS43209, US Department of Defense (W81XWH-13-1-0180 and W81XWH-18-1-0612), and the Heffer Family and the Segal Family Foundations, and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. DJ is director of the National Institutes of Health Countermeasures Against Chemical Threats Program. The author has no known conflicts of interest. The views expressed in this article are those of the authors and do not reflect the official policy of the NIH, Department of Health and Human Services, or the U.S. Government. No official support or endorsement of this article by the NINDS or NIH is intended or should be inferred. ASG is co-Editor in Chief of Epilepsia Open and has received royalties for publications from Elsevier and Morgan and Claypool publishers. She has received a one time honorarium for participation in an Eisai scientific advisory board. SLM is serving as Associate Editor of Neurobiology of Disease and is on the editorial board of Brain and Development, Pediatric Neurology and Physiological Research. He receives from Elsevier an annual compensation for his work as Associate Editor in Neurobiology of Disease and royalties from 2 books he co-edited. He has received consultant's fees from UCB, Mallinckrodt and Pfizer. Funding Information: SLM is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIH U54 NS100064 (EpiBioS4Rx), and NS43209 , US Department of Defense ( W81XWH-13-1-0180 and W81XWH-18-1-0612 ), and the Heffer Family and the Segal Family Foundations, and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. Funding Information: ASG acknowledges grant support by NINDS RO1 NS091170 , U54 NS100064 , the US Department of Defense ( W81XWH-13-1-0180 ), and research funding from the Heffer Family and the Segal Family Foundations and the Abbe Goldstein / Joshua Lurie and Laurie Marsh/ Dan Levitz families .
PY - 2020/1
Y1 - 2020/1
UR - http://www.scopus.com/inward/record.url?scp=85070859668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070859668&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2019.104557
DO - 10.1016/j.nbd.2019.104557
M3 - Editorial
C2 - 31374245
AN - SCOPUS:85070859668
SN - 0969-9961
VL - 133
JO - Neurobiology of Disease
JF - Neurobiology of Disease
M1 - 104557
ER -